SCHEMBL17430764

SCHEMBL17430764

CCCCCCNS(=O)(=O)c1ccc(C)c(C)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.63
HTT P42858 3/20 0.63
LMNA P02545 3/20 0.63
PKM P14618 3/20 0.56
ALDH1A1 P00352 8/20 0.52
MAPT P10636 2/20 0.52
GAA P10253 1/20 0.52
ALOX12 P18054 1/20 0.52
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
TSHR P16473 1/20 0.51
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
PDK1 Q15118 1/20 0.51
PDK2 Q15119 1/20 0.51
PDK3 Q15120 1/20 0.51
PDK4 Q16654 1/20 0.51
RECQL P46063 1/20 0.49
KDM4E B2RXH2 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14433417 0.94 HTT (0.58) MAPK1HTTLMNAPKMALDH1A1
SCHEMBL11108622 0.87 LMNA (0.59) MAPK1HTTLMNAPKMALDH1A1
SCHEMBL16502023 0.83 ALDH1A1 (0.63) MAPK1HTTLMNAPKMALDH1A1
SCHEMBL5696735 0.82 ALDH1A1 (0.72) MAPK1HTTLMNAPKMALDH1A1
SCHEMBL634183 0.82 ALDH1A1 (0.72) MAPK1HTTLMNAPKMALDH1A1
SCHEMBL223156 0.82 ALDH1A1 (0.72) MAPK1HTTLMNAPKMALDH1A1
SCHEMBL633648 0.82 ALDH1A1 (0.72) MAPK1HTTLMNAPKMALDH1A1
SCHEMBL8355315 0.82 ALDH1A1 (0.72) MAPK1HTTLMNAPKMALDH1A1
SCHEMBL7103280 0.82 ALDH1A1 (0.72) MAPK1HTTLMNAPKMALDH1A1
SCHEMBL634180 0.82 ALDH1A1 (0.72) MAPK1HTTLMNAPKMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9527878-B2 Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2016-12-27 US disclosed
US-20160009748-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITORS AND METHODS OF USE THEREOF TO MODULATE LIPID METABOLISM THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2016-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160009748-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITORS AND METHODS OF USE THEREOF TO MODULATE LIPID METABOLISM SERPINE1, PLAT, SERPINB1 MAPK1 1437/4885HTT 1212/4885LMNA 1156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.